Assessment of the Safety and Efficacy of Dupilumab in Children With Asthma (Liberty Asthma Excursion)
Public ClinicalTrials.gov record NCT03560466. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
One Year Study to Evaluate the Long-term Safety and Tolerability of Dupilumab in Pediatric Patients With Asthma Who Participated in a Previous Dupilumab Asthma Clinical Study
Study identification
- NCT ID
- NCT03560466
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Sanofi
- Industry
- Enrollment
- 378 participants
Conditions and interventions
Conditions
Interventions
- Asthma controller therapies (incl. prednisone/prednisolone) Drug
- Asthma reliever therapies Drug
- Dupilumab (SAR231893/REGN668) Drug
Drug
Eligibility (public fields only)
- Age range
- 6 Years to 11 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 20, 2018
- Primary completion
- Mar 31, 2025
- Completion
- Mar 31, 2025
- Last update posted
- Nov 20, 2025
2018 – 2025
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Allergy and Immunology Research- Site Number : 8400002 | Gilbert | Arizona | 85234 | — |
| Asthma and Airway Disease Research Center Site Number : 8400012 | Tucson | Arizona | 85274 | — |
| Peninsula Research Associates Site Number : 8400001 | Rolling Hills Estates | California | 90274 | — |
| Division of Pulmonary Medicine and Allergy Medicine- Site Number : 8400006 | St Louis | Missouri | 63110-1077 | — |
| Somnos Clinical Research Site Number : 8400022 | Lincoln | Nebraska | 68505 | — |
| Northwell Health- Site Number : 8400023 | Great Neck | New York | 11021 | — |
| Columbia University Medical Center- Site Number : 8400013 | New York | New York | 10032 | — |
| Rochester Regional Health- Site Number : 8400007 | Rochester | New York | 14607 | — |
| Immunocarolina LLC Site Number : 8400004 | Charlotte | North Carolina | 28277 | — |
| Cincinnati Children's Hospital Medical Center Site Number : 8400008 | Cincinnati | Ohio | 45229 | — |
| OK Clinical Research, LLC- Site Number : 8400024 | Edmond | Oklahoma | 73034 | — |
| Allergy & Asthma Research Center- Site Number : 8400003 | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 69 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03560466, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 20, 2025 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03560466 live on ClinicalTrials.gov.